OnTrackCF: Engagement, Feasibility, and Acceptability Study

Boston Children's Hospital

Status: Enrolling

Conditions: Cystic Fibrosis (CF); Cystic Fibrosis - Complete

Treatments: Behavioral: OnTrackCF

Study type: Interventional

Funder types: Other

Identifiers

NCT07031323

IRB-P00050537

Details and patient eligibility

About

This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).

Enrollment: 60 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Diagnosed with CF
2. 18+ years of age
3. Prescribed a CFTR modulator therapy to be taken twice a day
4. Can speak and read English
5. Have regular access to an iOS or Android tablet or smartphone with internet access.

Exclusion criteria

1) Any situation, in the opinion of the Investigator, that would compromise the safety of the patient or the quality of the data

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

60 participants in 1 patient group

Participation

Experimental group

Description:

Participants eligible to enroll will be provided with the OnTrackCF app (intervention), and will use the app for 4-12 weeks before completing feasibility measures and a qualitative interview.

Treatment:

Behavioral: OnTrackCF